Duality Advisers’s bluebird bio BLUE Stock Holding History

Duality Advisers’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,117	Closed	-$623K	–	642
2021 Q4	$623K	Sell	3,117 -919	-23%	-$217K	0.07%	379
2021 Q3	$999K	Sell	4,036 -3,261	-45%	-$932K	0.08%	353
2021 Q2	$3.02M	Buy	7,297 +2,623	+56%	+$1.04M	0.27%	123
2021 Q1	$1.82M	Sell	4,674 -2,656	-36%	-$1.31M	0.16%	237
2020 Q4	$4.11M	Buy	7,330 +2,929	+67%	+$1.86M	0.31%	79
2020 Q3	$3.08M	Buy	+4,401	New	+$3.43M	0.2%	135

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Duality Advisers's BLUE Position: Q1 2022 in Review

Duality Advisers sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 3,117 shares — an estimated $623K sold.

Duality Advisers first reported a position in BLUE in Q3 2020 and held it in 6 quarters. The position peaked at $4.11M in Q4 2020. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

Duality Advisers reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
Duality Advisers sold 3,117 bluebird bio shares in Q1 2022, an estimated $623K.
Duality Advisers first reported a position in bluebird bio in Q3 2020 and held it in 6 quarters.
Duality Advisers's bluebird bio position peaked at $4.11M in Q4 2020.
174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Duality Advisers's 13F filing for Q1 2022, filed 9 May 2022.